

Cover Story
Free
This series re-examines the concurrent controversies at the Cancer Prevention and Research Institute of Texas and MD Anderson Cancer Center. This examination is possible in part because of new insight provided by Alfred Gilman, a Nobel laureate who served as the first scientific director of the state institution that distributes $300 million a year. Gilman died on Dec. 23, 2015.
In Brief


Drugs & Targets
Trending Stories
- Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
- Charles Rudin named cancer center director at MSK
- Pam Bondi diagnosed with thyroid cancer
- As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- UK Markey’s Denise Fabian: Theranostics lets us pair a diagnostic with a radioactive therapeutic that target the same molecule











